Evidence map›Paper›PMID 28514675›Full record

ReviewImmunity2017

Metabolic Regulation of the Immune Humoral Response.

Mark Boothby, Robert C Rickert

Abstract readReview
In one paragraph

Review in Immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed.

  1. Trial
  2. Beyond the antibodies: serum metabolomic profiling of myasthenia gravis.Metabolomics : Official journal of the Metabolomic Society · 2019
    Trial
  3. SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Humoral immunity in cancer.Signal transduction and targeted therapy · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. RER1 regulates lipid metabolism in monocytes and macrophages.Cellular and molecular life sciences : CMLS · 2025
    Article
  17. Article
  18. Review
  19. Review
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark BoothbyDepartment of Pathology, Microbiology and Immunology, School of Medicine, Vanderbilt University, and Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Medicine, School of Medicine, Vanderbilt University, and Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: mark.boothby@vanderbilt.edu.
Robert C RickertTumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, CA 92037, USA; NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: robert@SBPdiscovery.org.

Funding

FUNCTION OF CD19 IN B CELL DEVELOPMENT/DIFFERENTIATIONR01AI041649 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI APGAR, JOHN R · 1998 to 2019
$7.0M
Roles of rictor in mTOR signaling, differentiation & immune memory via Akt & PKCR01HL106812 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOOTHBY, MARK R · 2011 to 2018
$3.1M
Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responsesR01AI113292 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOOTHBY, MARK R · 2015 to 2019
$1.9M
Novel biochemical and functional targets of PARPR21AI109690 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOOTHBY, MARK R · 2014 to 2015
$433k
Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responsesR56AI113292 · NIAID · VANDERBILT UNIVERSITY · PI BOOTHBY, MARK R · 2014 to 2014
$393k
NHLBI NIH HHS R01 HL106812NIAID NIH HHS R01 AI041649NIAID NIH HHS R01 AI113292NIAID NIH HHS R21 AI109690NIAID NIH HHS R56 AI113292
6 · The paper itself

Abstract

Productive humoral responses require that naive B cells and their differentiated progeny move among distinct micro-environments. In this review, we discuss how studies are beginning to address the nature of these niches as well as the interplay between cellular signaling, metabolic programming, and adaptation to the locale. Recent work adds evidence to the expectation that B cells at distinct stages of development or functional subsets are influenced by the altered profiles of nutrients and metabolic by-products that distinguish these sites. Moreover, emerging findings reveal a cross-talk among the external milieu, signal transduction pathways, and transcription factors that direct B cell fate in the periphery.

Indexed as

Energy MetabolismImmunity, HumoralAdaptive ImmunityAnimalsB-LymphocytesCell CycleCellular MicroenvironmentClonal Selection, Antigen-MediatedGene Expression RegulationGerminal CenterHomeostasisHumansImmune SystemImmunity, InnateLymphocyte Activation

Identifiers

PMID28514675
PMCPMC5640164

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.